Intimations To Stock Exchange | RPG Life Sciences
rpgls
  • Contact Us
  • Our Story
    • History and Milestones
    • Our Brand
    • Core Strengths
    • Vision, Values and Capabilities
    • Board of Directors
    • Management Team
    • Industry Awards and Recognition
  • Our Businesses
    • Business Portfolio
      • API
      • Domestic Formulations
      • International Formulations
      Manufacturing
      • Manufacturing Facilities
      • Quality
      • Environment, Health and Safety
      Scientific Overview
      • Research and Development
      • Patents
  • Therapeutic Focus
    • Nephrology
    • Rheumatology
    • Oncology
    • Urology
    • Anti-Diabetic
    • Respiratory
    • Gastroenterology
    • Cardiovascular
    • Gynaecology and Pediatrics
    • Vitamins and Minerals
    • Orthopedic
    • Neurology
    • Anti-Dengue
    • Dermatology
  • Life@RPGLS
    • Employee Connect
      Rewards and Recognition
      • Brave RPGLS Covid Warriors
      • Great Place To Work
      • Team Awards
      • Employee Awards
      Human Resources
      • Join Us
      • Company Events
      • Learning and Development
      CSR
      • Corporate Social Responsibility
      Explore Us
      Happiness Matters!!
  • Investors
    • Financial Results
      • Audited Financial Results
      • Quarterly Financial Results
      Company Presentations
      • Investor Presentations
      • Corporate Presentations
      • Earnings Call
      • Press Release
      Mandatory Disclosures
      • Code and Policies
      Shareholders Information
      • Shareholding Pattern
      • Concepts and Procedure
      • Corporate Governance Reports
      • Annual Reports
      • Intimation to Stock Exchange
      • Notices of Board Meetings
      • Outcome of Board Meetings
      • AGM & Postal Ballot
      • Unpaid Dividend List
      • TDS on Dividend Communication
      • Forms related to Physical Shares
      • Newspaper Publications
      • Market Tracker
      Investor Relations
      • Investor Education and Protection Fund
      • Investor Grievance
      • Investor Contacts
      • Investor Meets
      Committees Composition
      • Audit Committee
      • Risk Management Committee
      • Stakeholders Relationship Committee
      • Nomination & Remuneration Committee
      • CSR Committee
  • Media
    • Online News and Print Media
    • RPGLS @ Industry Platforms

INTIMATIONS TO STOCK EXCHANGE
  • Home
  • intimations to stock exchange

Sr. No. File Name (Click to Download)
1 Intimation of Loss of Share Certificate June 3,2022
2 Intimation of Loss of Share Certificate June 2,2022
3 Disclosure Regulation 23(9) - Related Party for Half year ended March 31, 2022
4 Annual Secretarial Compliance Report March 31, 2022
5 Intimation of Issue of Duplicate Certificate 29.04.22
6 Intimation about closing of Trading Window March 31, 2022
7 Intimation of Loss of Share Certificate March 8, 2022
8 Communication to Physical Shareholder for KYC submission February 7, 2022
9 Intimation of Loss of Shrare Certificate February 2, 2022
10 Intimation of Loss of Shrare Certificate January 17, 2022
11 Intimation about closing of Trading Window December 31, 2021
12 Intimation of Loss of Shrare Certificate December 29, 2021
13 Disclosure Regulation 23(9) - Related Party for Half year ended September 30, 2021
14 Intimation of Loss of Shrare Certificate November 24, 2021
15 Intimation of Loss of Shrare Certificate October 28, 2021
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Investors Information

Annual Conference Videos
  • June 16, 2021
  • Your browser does not support HTML5 video.
Company Presentations
  • Investor Presentations
  • Corporate Presentations
  • Earnings Call
  • Press Release
Financial Results
  • Audited Financial Results
  • Quarterly Financial Results
  • Dividend Declarations
Investor Relations
  • Investor Education and Protection Fund
  • Investor Grievance
  • Investor Contacts
  • Investor Meets
Share Holders Information
  • Shareholding Pattern
  • Concepts and Procedure
  • Corporate Governance Reports
  • Annual Reports
  • Intimation to Stock Exchange
  • Notices of Board Meetings
  • Outcome of Board Meetings
  • AGM & Postal Ballot
  • Unpaid Dividend List
  • TDS on dividend communication
  • Forms related to Physical Shares
  • Newspaper Publications
  • Market tracker
Board Committees
  • Audit Committee
  • Risk Management Committee
  • Stakeholders Relationship Committee
  • Nomination & Remuneration Committee
  • CSR Committee
Mandatory Disclosures
  • Code and Policies
Get in Touch

QUICK LINKS

Vision

Quality

History and Milestones

Company Awards

Manufacturing Facilities

Research and Development

Offline PDF form
Drugs Safety – Adverse Event Reporting

Contact Us

  • Address:
    RPG Life Sciences Limited,
    RPG HOUSE, 463, Dr. Annie Besant Road, Worli,
    Mumbai - 400030, India

  • Phone: +91 22 6660 6375 / 76 / 77

  • Fax: +91 22 2497 0127

  • Email:

Follow Us




Porto Website Template

RPG Life Sciences Limited © Copyright 2018-19. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Sitemap